Antidystonic efficacy of γ-aminobutyric acid uptake inhibitors in the dtsz mutant

European Journal of Pharmacology

Volumn 521, Issue 1-3, 2005, Pages 95-98

  Kreil, Annette ^a   Richter, Angelika ^a  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

Dyskinesia; GABA ( aminobutyric acid); Movement disorder

Indexed keywords

1 [2 (BENZHYDRYLIDENEAMINOOXY)ETHYL] 1,2,5,6 TETRAHYDRO 3 PYRIDINECARBOXYLIC ACID; 4 AMINOBUTYRIC ACID RECEPTOR BLOCKING AGENT; TIAGABINE;

4 AMINOBUTYRIC ACID UPTAKE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; DYSTONIA; GABAERGIC SYSTEM; HAMSTER; LATENT PERIOD; LOCOMOTION; MUTANT; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; CRICETINAE; DISEASE PROGRESSION; DOSE-RESPONSE RELATIONSHIP, DRUG; DYSTONIA; FEMALE; GABA ANTAGONISTS; INJECTIONS, INTRAPERITONEAL; MALE; MUTATION; NIPECOTIC ACIDS; OXIMES; RANDOM ALLOCATION; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME;

EID: 26444569923     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2005.08.041     Document Type: Article

References (19)

1. J.J. Anderson, and J.A. DiMicco The use of microdialysis for studying the regional effects of pharmacological manipulation on extracellular levels of amino acids-some methodological aspects Life Sci. 51 1992 623 630
2. 67 immunoreactivity, and parvalbumin mRNA J. Neurosci. 15 1995 865 874
3. L.A. Borden GABA transporter heterogeneity: pharmacology and cellular localization Neurochem. Int. 29 1996 335 356
4. L.A. Borden, T.G. Murali Dhar, K.E. Smith, R.L. Weinshank, T.A. Branchek, and C. Gluchowski Tiagabine, SK and F 89976-A, CI-966, and NNC-711 are selective for the cloned GABA transporter GAT-1 Eur. J. Pharmacol. 269 1994 219 224
5. S. Fahn Medical treatment of dystonia J.K.C. Tsui C.B. Calne Handbook of Dystonia 1995 Marcel Dekker New York 317 328
6. M. Gernert, M. Hamann, M. Bennay, W. Löscher, and A. Richter Deficit of striatal parvalbumin-reactive GABAergic interneurons and decreased basal ganglia output in a genetic rodent model of idiopathic paroxysmal dystonia J. Neurosci. 20 2000 7052 7058
7. M. Hamann, and A. Richter Effects of striatal injections of GABAA receptor agonists and antagonists in a genetic animal model of paroxysmal dystonia Eur. J. Pharmacol. 443 2002 59 70
8. B.I. Kanner Sodium-coupled neurotransmitter transport: structure, function and regulation J. Exp. Biol. 196 1994 237 249
9. P. Krogsgaard-Larsen, B. Frolund, and K. Frydenvang GABA uptake inhibitors. Design, molecular pharmacology and therapeutic aspects Curr. Pharm. Des. 6 2000 1193 1209
10. H. Kubova NNC-711: an inhibitor of GABA uptake with selective affinity to GAT-1 CNS Drug Rev. 5 1999 317 330
11. S.M. LaRoche, and S.L. Helmers The new antiepileptic drugs: scientific review JAMA 291 2004 605 614
12. L.M. Levy, and M. Hallett Impaired brain GABA in focal dystonia Ann. Neurol. 51 2002 93 101
13. N. Nardocci, E. Fernandez-Alvarez, N.W. Wood, S.D. Spacy, and A. Richter The paroxysmal dyskinesias R. Guerrini J. Aicardi F. Andermann M. Hallett Epilepsy and Movement Disorders 2002 Cambridge University Press Cambridge 125 139
14. S.C. Schachter Pharmacology and clinical experience with tiagabine Exp. Opin. Pharmacother. 2 2001 179 187
15. A. Richter The genetically dystonic hamster: an animal model of paroxysmal dystonia M. LeDoux Animal Models of Movement Disorders 2005 Elsevier Academic Press San Diego 459 466
16. A. Richter, and W. Löscher Pathophysiology of idiopathic dystonia: findings from genetic animal models Prog. Neurobiol. 54 1998 633 677
17. A. Richter, and W. Löscher Gabapentin decreases the severity of dystonia at low doses in a genetic animal model of paroxysmal dystonic choreoathetosis Eur. J. Pharmacol. 369 1999 335 338
18. M.A. Rogawski, and W. Löscher The neurobiology of antiepileptic drugs for the treatment of nonepileptic conditions Nat. Med. 10 2004 685 692
19. P.D. Suzdak Lack of tolerance to the anticonvulsant effects of tiagabine following chronic (21-day) treatment Epilepsy Res. 19 1994 205 213